FDA announced on Dec. 23, 2014 that it had approved Roche Diagnostics Ebola test for emergency use. The LightMix Ebola Zaire rRT-PCR (real-time reverse transcription polymerase chain reaction) test is designed for use in patients with symptoms related to the Ebola Zaire virus. The testOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.